|Submission Date||: May 14, 2015|
|Acceptance Date||: May 30, 2015|
|Publishing Date||: June 3,2015|
|Type of Paper||: Research Article|
|Mode of Access||: Open Access|
|Author||: Suneel Bhooshan1, Dr Ankur Goyal2, Dr Arti Agrawal2, Vinay Verma2|
|Affiliation||:1 Department of Microbiology, AIIMS Bhopal2 Departments of Microbiology, S.N. Medical College, Agra|
More than 17 species has been identified as causative agent of candidaemia. Identification of Candida species may help in selecting antifungal agents in severely ill ICU patients as the drug resistance continues to be a potential risk factor for cost effectiveness of treatment and outcome. This prospective study was conducted to identify the pattern of prevalence and drug resistance in Candida species. Total 60 isolates were identified and screened for drug resistance from ICU patients. Most commonly isolated species was C. albicans (41.66%) followed by C. Tropicalis (23.33%). Highest drug resistance was seen towards Itraconazole and Fluconazole. All Candida isolates remain susceptible to Voriconazole. Early diagnosis and prompt treatment can help in patient management and improve treatment outcome.